Tuesday, November 5, 2024

Bayer Commits to Veeva Vault CRM and Veeva OpenData Globally

Related stories

Crayon Joins AWS Generative AI Partner Innovation Alliance

Crayon announced it will work with Amazon Web Services...

Sikich announced the appointment of Ray Beste as Principal AI Strategist

Sikich, a Chicago-based leading global technology-enabled professional services company,...

Wondershare Unveils SelfyzAI 3.0: New AI Features Enhance Image Editing Experience

Wondershare proudly launched SelfyzAI 3.0, the latest version of...

Dan Muscatello Joins OneSix as Chief Revenue Officer

OneSix, a leading data and artificial intelligence (AI) consultancy...
spot_imgspot_img

Veeva Systems announced that Bayer will be among the first 20 major biopharmaceuticals to migrate to Veeva Vault CRM  worldwide, while standardizing global data of customers with Veeva OpenData . As Bayer moves to Vault CRM, the next generation of CRM for life sciences, it is harmonizing customer reference data for greater efficiency and continued innovation in the future. By unifying its global master data, Bayer will be poised to leverage AI-powered engagement across channels and geographies.

“Partnering with Veeva provides us with the long-term data and technology foundation to gain the speed and agility needed for the complexities of modern medicine,” said Patrick Moeller , global head of commercial IT and digital pharmacy at Bayer. “Vault CRM and Veeva OpenData are essential to driving more accurate and effective customer engagement across every region and therapeutic area.”

Bayer currently relies on Veeva CRM  to drive omnichannel engagement with healthcare professionals (HCPs) and launch new medicines in more than 80 countries. Bayer will expand its use of Veeva OpenData to replace legacy data products with consistent, high-quality customer reference data around the world. By optimizing its global data landscape, Bayer can deliver more accurate and timely data to field teams to better serve its customers.

Also Read: Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection

“Bayer and Veeva will continue our long-term partnership, working together to help their medical, sales and marketing teams bring new and complex medicines to global markets with speed and precision,” said Tom Schwenger, president and chief operating officer . by Veeva. “Vault CRM and Veeva OpenData will provide the foundation for business innovation to drive more effective on-demand engagement, expanding relationships with healthcare professionals around the world.”

Keynote speakers from Bayer, along with 20 other leading biopharmaceutical companies, will open the Veeva Commercial Summit in Europe and share how Vault CRM is a key enabler of future business agility, innovation and differentiation. Vault CRM is part of Veeva Commercial Cloud , the software foundation for business excellence. Veeva OpenData is part of Veeva Data Cloud , the modern life sciences data platform that connects commercial and clinical for greater accuracy and speed.

SOURCE: PRNewswire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img